MARACA International

MARACA International, located in Belgium, the heart of Europe, offers a complete list of services to assist the manufacturer in obtaining the CE-mark and or FDA approval for his products. MARACA provides regulatory, medical and clinical services to Pharma, Medical Device and Invitro Diagnostic Device companies, clinical laboratories and notified bodies.

Regulatory Services for CE-Marking and FDA submission

Full or partial management of your regulatory activities.  General consulting and training on the new MDR and IVDR Regulations, the US 21CFR regulations and their impact on your business. Composition or review of your design dossier for NB assessment or third party FDA review. Review of your IFU and product labels. Advise in the design of labeling and Unique Device Identifier (UDI). Gap analysis of your quality system versus the requirements of the MDD/MDR or IVDD/IVDR Regulation,  or the 21CFR 820 and ISO13485. Advice in the classification of medical devices, IVDs, software and health applications. Composition of performance evaluation plans and reports. Organization of clinical performance evaluation studies. Your ambassador with NB, CA, FDA, CFDA interactions and submissions. Management of incidents: Health hazard assessment, incident notification, recall and advisory notices.

Unique service as medical Practitioner for Design Review, Risk-Benefit Summary, Health Hazard Assessment, Clinical Evaluation Report (CER), Clinical study protocols & reports and Ambassador to NB & FDA.

Unique service

For Performance Evaluations, we offer Scientific Validity Reports & Clinical Validity Reports with Lit. review; Clinical Evaluation Reports (CER) with Lit. review & Gap analysis; Clinical Investigation Plans & Reports and PMCF Plans and Reports.

Performance Evaluations

MARACA International BVBA

Heirbaan 143,3110 Rotselaar

Belgium, Europe

Tel +32476960153

Go to article: Home | Regulation: ready for the digital age?Go to article: In this issueGo to article: TelemedGo to article: Telemed Company InsightGo to article: ContentsGo to article: ARPAGo to article: NewsGo to article: Tricor SystemsGo to article: Will automation take over healthcare jobs? Industry experts share their opinionGo to article: MikronGo to article: Is regulation ready for the rise of digital health products?Go to article: Scandinavian Health Ltd Company insightGo to article: Scandinavian Health LtdGo to article: Laboratory-developed tests are under the regulatory spotlightGo to article: Micro Systems Technologies Management AGGo to article: 23andMe's at-home genetic test is now approved for breast cancerGo to article: Art of TechnologyGo to article: FDA approves first AI device to detect diabetic retinopathyGo to article: BISAGo to article: New wearable MRI scanner could read your mindGo to article: Frankfurt Laser CompanyGo to article: Frankfurt Laser Company | Company InsightGo to article: Rising number of surgical procedures to drive sutures market to $4.5bn by 2024Go to article: FormacoatGo to article: Formacoat Company InsightGo to article: Med Tech trade post-Brexit: it's time to take actionGo to article: MPS Microsystems Go to article: MPS Microsystems Company InsightGo to article: Inside the UK's new healthcare photonics centreGo to article: raPHARMGo to article: Virtual surgery: the healthcare potential of augmented realityGo to article: Alpha TechnicsGo to article: Upcoming events for the medical devices industryGo to article: AerotechGo to article: Event: AchemaGo to article: Nelson LabGo to article: Event: EPHJ-EPMT-SMTGo to article: AccumoldGo to article: Next issue previewGo to article: Maraca International